• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology - Neuro-Otology.紧张部胆脂瘤的临床特征:日本耳科学会与欧洲耳科学-神经耳科学学会提出的基于区域的分类系统的比较研究
J Int Adv Otol. 2019 Aug;15(2):184-188. doi: 10.5152/iao.2019.6349.
2
Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.使用EAONO/JOS分期系统评估松弛部胆脂瘤鼓室成形术的短期听力预后
J Int Adv Otol. 2019 Apr;15(1):2-7. doi: 10.5152/iao.2019.5983.
3
Congenital cholesteatoma assessment based on staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.基于日本耳科学会提出的中耳胆脂瘤分期和分类标准对先天性胆脂瘤进行评估。
Auris Nasus Larynx. 2021 Apr;48(2):201-206. doi: 10.1016/j.anl.2020.07.022. Epub 2020 Aug 13.
4
EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.欧洲耳鼻咽喉头颈外科学会/日本耳科学会关于中耳胆脂瘤定义、分类及分期的联合共识声明
J Int Adv Otol. 2017 Apr;13(1):1-8. doi: 10.5152/iao.2017.3363. Epub 2017 Jan 6.
5
Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan.日本耳科学会提出的后天性中耳胆脂瘤分期系统的实用性分析:日本446例手术病例的多中心研究
Auris Nasus Larynx. 2018 Feb;45(1):45-50. doi: 10.1016/j.anl.2017.02.005. Epub 2017 Mar 6.
6
Nationwide survey of middle ear cholesteatoma surgery cases in Japan: Results from the Japan Otological society registry using the JOS staging and classification system.日本全国中耳胆脂瘤手术病例调查:日本耳科学会登记处采用JOS分期和分类系统的结果。
Auris Nasus Larynx. 2021 Aug;48(4):555-564. doi: 10.1016/j.anl.2020.09.011. Epub 2020 Sep 25.
7
Practical analysis of pars flaccida cholesteatoma with classification and staging system proposed by Japan Otological Society: a comparative study.日本耳科学会提出的松弛部胆脂瘤分类及分期系统的实践分析:一项比较研究
Acta Otolaryngol. 2018 Nov;138(11):977-980. doi: 10.1080/00016489.2018.1498593. Epub 2019 Feb 11.
8
Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.日本耳科学会提出的中耳胆脂瘤分期及分类标准。
Auris Nasus Larynx. 2017 Apr;44(2):135-140. doi: 10.1016/j.anl.2016.06.012. Epub 2016 Sep 9.
9
Nationwide survey of congenital cholesteatoma using staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.使用日本耳科学会提出的中耳胆脂瘤分期和分类标准对先天性胆脂瘤进行全国性调查。
Auris Nasus Larynx. 2019 Jun;46(3):346-352. doi: 10.1016/j.anl.2018.10.015. Epub 2018 Nov 8.
10
Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System.获得性中耳胆脂瘤的手术结果与分期的相关性:EAONO/JOS 分期系统的再验证。
J Int Adv Otol. 2020 Apr;16(1):34-39. doi: 10.5152/iao.2020.7598.

引用本文的文献

1
Postoperative Hearing Outcomes and Usefulness of Endoscopy-Assisted Tympanoplasty in Pars Tensa Cholesteatoma.鼓膜紧张部胆脂瘤患者内镜辅助鼓室成形术的术后听力结果及实用性
Int Arch Otorhinolaryngol. 2025 Jan 10;29(1):1-7. doi: 10.1055/s-0044-1792016. eCollection 2025 Jan.
2
Cholesteatoma Classification: Review of Literature and Proposed Indian Classification System-TAMPFIC.胆脂瘤分类:文献综述及拟议的印度分类系统——TAMPFIC
Indian J Otolaryngol Head Neck Surg. 2022 Aug;74(Suppl 1):402-409. doi: 10.1007/s12070-020-02154-8. Epub 2020 Sep 29.
3
Facial Nerve Dehiscence and Cholesteatoma: A Comparison between Decades.面神经裂和胆脂瘤:数十年间的比较。
J Int Adv Otol. 2020 Dec;16(3):367-372. doi: 10.5152/iao.2020.8395.

本文引用的文献

1
Transcanal Endoscopic Ear Surgery for Middle Ear Cholesteatoma.经耳道内镜中耳胆脂瘤手术
Otol Neurotol. 2017 Jun;38(5):e41-e45. doi: 10.1097/MAO.0000000000001395.
2
Cholesteatoma Definition and Classification: A Literature Review.胆脂瘤的定义与分类:文献综述
J Int Adv Otol. 2017 Aug;13(2):266-271. doi: 10.5152/iao.2017.3411. Epub 2017 Mar 9.
3
Practicality analysis of the staging system proposed by the Japan Otological Society for acquired middle ear cholesteatoma: A multicenter study of 446 surgical cases in Japan.日本耳科学会提出的后天性中耳胆脂瘤分期系统的实用性分析:日本446例手术病例的多中心研究
Auris Nasus Larynx. 2018 Feb;45(1):45-50. doi: 10.1016/j.anl.2017.02.005. Epub 2017 Mar 6.
4
EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear Cholesteatoma.欧洲耳鼻咽喉头颈外科学会/日本耳科学会关于中耳胆脂瘤定义、分类及分期的联合共识声明
J Int Adv Otol. 2017 Apr;13(1):1-8. doi: 10.5152/iao.2017.3363. Epub 2017 Jan 6.
5
Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.日本耳科学会提出的中耳胆脂瘤分期及分类标准。
Auris Nasus Larynx. 2017 Apr;44(2):135-140. doi: 10.1016/j.anl.2016.06.012. Epub 2016 Sep 9.
6
Classification of Cholesteatoma According to Growth Patterns.根据生长模式对胆脂瘤进行分类。
JAMA Otolaryngol Head Neck Surg. 2016 Feb;142(2):168-72. doi: 10.1001/jamaoto.2015.3148.
7
Consensus-Based Recommendations on the Definition and Classification of Cholesteatoma.基于共识的胆脂瘤定义与分类建议。
J Int Adv Otol. 2015 Apr;11(1):81-7. doi: 10.5152/iao.2015.1206.
8
Acquired cholesteatoma in children: clinical features and surgical outcome.儿童获得性胆脂瘤:临床特征与手术结果
Auris Nasus Larynx. 2014 Oct;41(5):417-21. doi: 10.1016/j.anl.2014.05.002. Epub 2014 Jun 2.
9
Differences in middle ear ventilation disorders between pars flaccida and pars tensa cholesteatoma in sonotubometry and patterns of tympanic and mastoid pneumatization.声导抗测试中耳鼓室负压和乳突气房分型中耳传音结构鼓室病变的差异。
Otol Neurotol. 2012 Jul;33(5):765-8. doi: 10.1097/MAO.0b013e318254fb85.
10
Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases.中耳和乳突胆脂瘤的流行病学:1146 例研究。
Braz J Otorhinolaryngol. 2011 Jun;77(3):341-7. doi: 10.1590/s1808-86942011000300012.

紧张部胆脂瘤的临床特征:日本耳科学会与欧洲耳科学-神经耳科学学会提出的基于区域的分类系统的比较研究

Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology - Neuro-Otology.

作者信息

Motegi Masaomi, Yamamoto Yutaka, Tada Takeshi, Takahashi Masahiro, Sampei Sayaka, Sano Hiromi, Morino Tsunetaro, Komori Manabu, Miura Masahiro, Yamamoto Kazuhisa, Yaguchi Yuichiro, Sakurai Yuika, Kojima Hiromi

机构信息

Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.

Department of Otorhinolaryngology, St. Marianna University School of Medicine, Kanagawa, Japan.

出版信息

J Int Adv Otol. 2019 Aug;15(2):184-188. doi: 10.5152/iao.2019.6349.

DOI:10.5152/iao.2019.6349
PMID:31287432
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6750777/
Abstract

OBJECTIVES

To assess the clinical characteristics of extent patterns in pars tensa cholesteatoma.

MATERIALS AND METHODS

This was a retrospective chart review. Forty-four patients with pars tensa cholesteatoma who underwent primary surgery at a tertiary academic medical center were included. The main outcomes measured were sex, age, clinical background, and stage classification of pars tensa cholesteatoma (including the extent of cholesteatoma and involvement of the sinus tympani) according to two staging classifications: criteria advocated by the Japanese Otological Society (JOS) and those advocated by the European Academy of Otology and Neuro-Otology (EAONO)/JOS joint consensus statements.

RESULTS

The mean patient age ± standard deviation was 38.4±19.6 years. The patients comprised 19 men and 25 women. According to the JOS classification, 18 ears (40.9%) were classified as stage I, 22 (50.0%) as stage II, and 4 (9.1%) as stage III. According to the EAONO/JOS joint consensus statements, 14 ears (31.8%) were classified as stage I, 26 (59.1%) as stage II, and 4 (9.1%) as stage III. Fourteen ears (31.8%) demonstrated involvement of the sinus tympani. Four ears (9.1%) that were originally categorized as stage I cholesteatoma by the JOS criteria showed sinus tympani invasion and were subsequently categorized as stage II according to the EAONO/JOS criteria.

CONCLUSION

We determined the clinical characteristics of pars tensa cholesteatoma based on the novel and well-defined classification criteria. Further studies including long-term outcomes are necessary to demonstrate the clinical relevance of the discrepancy between the two criteria with respect to involvement of the sinus tympani.

摘要

目的

评估紧张部胆脂瘤范围模式的临床特征。

材料与方法

这是一项回顾性病历审查。纳入了在一家三级学术医疗中心接受初次手术的44例紧张部胆脂瘤患者。根据两种分期分类法测量的主要结果包括性别、年龄、临床背景以及紧张部胆脂瘤的分期分类(包括胆脂瘤范围和鼓室窦受累情况):日本耳科学会(JOS)倡导的标准以及欧洲耳科学与神经耳科学学会(EAONO)/JOS联合共识声明倡导的标准。

结果

患者的平均年龄±标准差为38.4±19.6岁。患者包括19名男性和25名女性。根据JOS分类,18耳(40.9%)被分类为I期,22耳(50.0%)为II期,4耳(9.1%)为III期。根据EAONO/JOS联合共识声明,14耳(31.8%)被分类为I期,26耳(59.1%)为II期,4耳(9.1%)为III期。14耳(31.8%)显示鼓室窦受累。4耳(9.1%)最初根据JOS标准被分类为I期胆脂瘤,显示有鼓室窦侵犯,随后根据EAONO/JOS标准被重新分类为II期。

结论

我们基于新颖且明确的分类标准确定了紧张部胆脂瘤的临床特征。有必要进行包括长期结果在内的进一步研究,以证明两种标准在鼓室窦受累方面差异的临床相关性。